Instil Bio, Inc.
TIL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001789769
No open-market purchases or sales by Instil Bio, Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $29.2M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Instil Bio, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 79
- −15 vs. Q3 2022
- Shares held
- 101.7M
- −17.5M (−14.7%) vs. Q3 2022
- Total value
- $64.1M
- −$512.9M (−88.9%) vs. Q3 2022
- New holders
- 19
- 23 more added
- Sold out
- 34
- 22 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TIL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 26 | $29.2M |
| Q1 2026 | 32 | $34.6M |
| Q4 2025 | 29 | $48.9M |
| Q3 2025 | 34 | $81.3M |
| Q2 2025 | 38 | $96.9M |
| Q1 2025 | 43 | $91.2M |
| Q4 2024 | 40 | $100.0M |
| Q3 2024 | 49 | $358.0M |
| Q2 2024 | 30 | $43.5M |
| Q1 2024 | 31 | $45.9M |
| Q4 2023 | 30 | $30.0M |
| Q3 2023 | 58 | $34.3M |
| Q2 2023 | 62 | $45.3M |
| Q1 2023 | 73 | $60.9M |
| Q4 2022 | 79 | $64.1M |
| Q3 2022 | 95 | $577.0M |
| Q2 2022 | 99 | $550.9M |
| Q1 2022 | 79 | $1.27B |
| Q4 2021 | 77 | $1.99B |
| Q3 2021 | 64 | $1.28B |
| Q2 2021 | 62 | $1.35B |
| Q1 2021 | 56 | $1.62B |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Instil Bio, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Corton Capital Inc. | 0 | $0 | 0.00% | −21,954−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −21,404−100.0% | Sold out |
| Victory Capital Management Inc | 0 | $0 | 0.00% | −19,348−100.0% | Sold out |
| Martingale Asset Management L P | 0 | $0 | 0.00% | −18,903−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −20,300−100.0% | Sold out |
| Amundi | 0 | $0 | 0.00% | −9,261−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −8,847−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −3,809−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −131−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −166−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −109−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −28−100.0% | Sold out |
| Community Bank, N.A. | 0 | $0 | 0.00% | −18−100.0% | Sold out |
| ACT Capital Management, LLC | – | – | – | – | Not filed |